help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, J. L.
Right arrow Articles by Zinn, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, J. L.
Right arrow Articles by Zinn, A. R.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5674-5680
Copyright © 2001 by The Endocrine Society


Special Features

Phenotypes Associated with SHOX Deficiency

Judith L. Ross, Charles Scott, Jr., Pia Marttila, Karen Kowal, Andrea Nass, Peter Papenhausen, Jack Abboudi, Lee Osterman, Harvey Kushner, Peter Carter, Marybeth Ezaki, Frederick Elder, Fanglin Wei, Huaqun Chen and Andrew R. Zinn

Departments of Pediatrics (J.L.R., C.S., K.K., A.N.) and Orthopedic Surgery (J.A., L.O.), Thomas Jefferson University, Philadelphia, Pennsylvania 19107; Alfred I. DuPont Hospital for Children (J.L.R., C.S.), Wilmington, Delaware 19803; Molecular Endocrinology, Research and Development (P.M.), Esoterix Endocrinology, Calabasas Hills, California 91301; Laboratory Corporation of America (P.P.), Research Triangle Park, North Carolina 27709; Biomedical Computing (H.K.), Philadelphia, Pennsylvania 19115; Texas Scottish Rite Hospital for Children (P.C., M.E.), Dallas, Texas 75219; Department of Pathology (F.E.), The University of Texas Southwestern Medical School, Dallas, Texas 75219; and Eugene McDermott Center for Human Growth and Development and Department of Internal Medicine (F.W., H.C., A.R.Z.), The University of Texas Southwestern Medical School, Dallas, Texas 75390

Address all correspondence and requests for reprints to: Judith L. Ross, M.D., Thomas Jefferson University, Department of Pediatrics, 1025 Walnut Street, Philadelphia, Pennsylvania 19107. E-mail: Judith.Ross@mail.tju.edu (or Andrew.Zinn{at}UTSouthwestern.edu)

Abstract

Leri-Weill dyschondrosteosis (LWD) (MIM 127300) is a dominantly inherited skeletal dysplasia characterized phenotypically by Madelung wrist deformity, mesomelia, and short stature. LWD can now be defined genetically by haploinsufficiency of the SHOX (short stature homeobox-containing) gene. We have studied 21 LWD families (43 affected LWD subjects, including 32 females and 11 males, ages 3–56 yr) with confirmed SHOX abnormalities. We investigated the relationship between SHOX mutations, height deficit, and Madelung deformity to determine the contribution of SHOX haploinsufficiency to the LWD and Turner syndrome (TS) phenotypes. Also, we examined the effects of age, gender, and female puberty (estrogen) on the LWD phenotype.

SHOX deletions were present in affected individuals from 17 families (81%), and point mutations were detected in 4 families (19%). In the LWD subjects, height deficits ranged from -4.6 to +0.6 SD (mean ± SD = -2.2 ± 1.0). There were no statistically significant effects of age, gender, pubertal status, or parental origin of SHOX mutations on height z-score. The height deficit in LWD is approximately two thirds that of TS. Madelung deformity was present in 74% of LWD children and adults and was more frequent and severe in females than males. The prevalence of the Madelung deformity was higher in the LWD vs. a TS population. The prevalence of increased carrying angle, high arched palate, and scoliosis was similar in the two populations.

In conclusion, SHOX deletions or mutations accounted for all of our LWD cases. SHOX haploinsufficiency accounts for most, but not all, of the TS height deficit. The LWD phenotype shows some gender- and age-related differences.

LERI-WEILL DYSCHONDROSTEOSIS (LWD) (MIM 127300) is a dominantly inherited skeletal dysplasia first described in 1929 (1). The phenotype includes Madelung’s deformity of the wrist, mesomelia, and short stature. Madelung wrist deformity likely originates with disorganized growth of part of the radial epiphysis, leading to radial bowing, premature fusion of that epiphysis, dorsal dislocation of the ulna, and wedged carpal bones (2).

The molecular basis for LWD was recently described (3, 4, 5). A gene on the distal part of the pseudoautosomal region, SHOX (short stature homeobox-containing gene), was cloned (6) and related to the short stature that is nearly universal in 45,X Turner syndrome (TS, monosomy X). SHOX is expressed by both sex chromosomes in males and females and is thought to play a role in bone growth and development. The importance of SHOX in TS linear growth was supported by the finding of similar growth patterns in 1 of 91 idiopathic short stature patients with a SHOX nonsense mutation (~1%) and TS females (6). Haploinsufficiency for the SHOX gene is also associated with LWD (3, 7); SHOX deletions or mutations were found in 60–100% of LWD cases (4, 8).

The discovery that SHOX deficiency causes LWD prompted reexamination of its role in TS. Clement-Jones et al. (9) found robust SHOX expression in early human embryos in the mid-portions of the developing limbs as well as the first and second pharyngeal arches. They hypothesized that SHOX haploinsufficiency causes TS skeletal features such as cubitus valgus and short fourth metacarpals, as well as TS craniofacial abnormalities such as high arched palate and micrognathia. Retrospective clinical examination of subjects with known SHOX mutations (without TS) revealed cubitus valgus, short fourth metacarpals, short neck, and scoliosis in some individuals (9). These individuals did not have TS but shared some skeletal features of TS, presumably due to SHOX haploinsufficiency. Thus, TS and LWD share both SHOX haploinsufficiency and associated phenotypic features such as short stature and skeletal anomalies. However, TS is distinguished from LWD by its additional growth deficit, ovarian failure, and extra-skeletal features.

We have prospectively studied 21 LWD families to investigate the relationship between SHOX deficiency and other TS skeletal features (short stature, mesomelia, Madelung deformity, increased carrying angle, and palate morphology). Our study included precise molecular description of the SHOX abnormalities and detailed phenotypic descriptions. We compared the phenotype of LWD patients with SHOX point mutations vs. larger deletions encompassing SHOX (but limited to Xp22.3) to determine whether contiguous genes play a role in the LWD phenotype. We also examined the effects of age, gender, and puberty (estrogen) on the phenotype. The comprehensive evaluation of these LWD subjects sheds light on the normal role of SHOX in bone growth and development and the contribution of SHOX haploinsufficiency to Turner syndrome.

Subjects and Methods

Methods

SHOX deletions were detected by fluorescence in situ hybridization (FISH) using cosmid probe LLNOYCO3'M'34F5 as previously described (10). At least five metaphases were scored for each sample.

SHOX mutations were detected by denaturing HPLC (DHPLC) using the Transgenomic WAVE system. Primers and DHPLC conditions will be described elsewhere (Marttila, P., J. Ross, M. Stene, S. Blakely, J. Sernberger, and A. Zinn, manuscript in preparation). Mutations were confirmed by direct sequencing of genomic PCR products.

Parental origin of deletions was inferred from pedigrees or from parental karyotypes for deletions due to unbalanced translocations.

Karyotypes were obtained from subjects when possible. For purposes of differentiating LWD and TS, LWD cases with an abnormal karyotype were defined as LWD only if the karyotype result was a nonmosaic deletion encompassing distal Xp22.3 only.

Subjects

Subjects were generally referred for short stature or Madelung deformity. The study was approved by the Human Studies Committee at Thomas Jefferson University and The University of Texas Southwestern Medical School, and informed consent or assent was obtained in all cases. None of the patients had received GH treatment. The clinical assessment included measurement of height, lower segment, arm span, and forearm length. High arched palate, increased carrying angle of the arms, and scoliosis were evaluated as previously described (11). Arm span was measured as the distance from right to left third finger tips with patients facing the wall, with outstretched arms held parallel to the ground. Results were converted to z-scores where possible using age- and gender-specific norms (12, 13, 14). Pubertal development was assessed according to standard methods (15). Age of onset of menarche in females was recorded.

Metacarpal-phalangeal profiles measured from hand x-rays were used to determine the presence of short fourth or fifth metacarpals (16). Age- and gender-specific height z-scores were calculated from National Center for Health Statistics (12). Z-scores for right radial length and ratio of upper to lower segment were calculated from published norms (14). A positive z-score means the ratio (upper to lower segment) was greater than normal, indicating relatively short legs.

Radial length was measured from the olecranon to the radial prominence by physical examination. The presence of Madelung deformity was assessed by the following defined measurements on AP and lateral wrist x-rays. Carpal wedging was defined as the age- and gender-specific z-score of the angle between the tangents of the proximal scapholunate and lunotriquetral surfaces (13). Radial lucency was defined as the presence of radiographic lucency, particularly in the ulnar border of the radius measured relative to metaphyseal width, in line with the ulnar corner and perpendicular to the long axis of the radius. Ulnar variance was defined as the distance between the perpendicular to the long axis of the ulna at the tip of the ulnar head and the ulnar corner of the radius. The third metacarpal radial angle was defined as the angle between the long axis of the third metacarpal and the long axis of the radius. Subluxation of the ulnar head was defined as the relative percentage of ulnar head dorsal to radius, compared with the width of the ulnar head. Control x-rays from anonymous normal individuals were used for comparison purposes. Bone age was calculated according to the method of Greulich and Pyle (17).

Heights from 25 women with 45,X Turner syndrome who had received no growth-promoting treatment were used in the comparisons with LWD adults.

Statistics

Continuous variables were compared by unpaired t test, and dichotomous variables were compared by {chi}2 analysis. Pearson correlations were calculated to examine the relationship of the variables with age. We applied a Bonferroni correction for multiple comparisons. Only results for which the P value was less than 0.001 were considered statistically significant. However, all observed, unadjusted P values are presented. Some comparisons with P values greater than 0.001 would have been significant if they were the primary endpoints alone.

Results

Molecular analysis of SHOX deletions and mutations

SHOX abnormalities were identified in all 21 LWD families (Table 1Go). Complete gene deletion was detected by FISH (Fig. 1Go) in 33 subjects from 17 unrelated families. Nine of these kindreds had probands with karyotypic abnormalities, which were the basis for ascertainment for this study. Five families had probands with normal karyotypes. No karyotype results were available from three families. One of these three families had an undiagnosed X;autosome translocation determined by FISH that was balanced in the mother and unbalanced in the proband.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical data from LWD subjects

 


View larger version (49K):
[in this window]
[in a new window]
 
Figure 1. Partial metaphase from subject SW368 showing deletion of SHOX gene on one X chromosome. SHOX, Cosmid probe (see Subjects and Methods); Xcen, control probe for X chromosome centromeric repeat DXZ1.

 
SHOX point mutations (Fig. 2Go) were identified in four families by DHPLC and confirmed by DNA sequencing. Three mutations were novel. One was a frameshift due to deletion of a single base pair at nucleotide 358, numbering from the translation start site (Fig. 2Go, del358A). The frameshift results in a predicted protein of 128 amino acids lacking the homeodomain. The mutation was present in a father and daughter (SW386 and SW387) who both had LWD. Another family had a transversion from A to T at nucleotide 383, resulting in substitution of leucine for an evolutionarily conserved glutamine at amino acid 128 within the homeodomain (Fig. 2Go, Q128L). This mutation was present in a father with LWD (SW427) and two affected daughters (SW391, SW425). Another missense mutation was a transition from T to C at nucleotide 461, which replaces leucine at residue 154 with proline, also within the homeodomain (Fig. 2Go, L154P). This substitution would likely alter the secondary structure of the protein and interfere with DNA binding. This mutation was present in a mother with LWD (SW343) and her affected daughter (SW344). The fourth mutation was a nonsense mutation at codon 195 (Fig. 2Go, R195X), present in a mother with LWD (SW435) and two affected daughters (SW366, SW367). None of the SHOX point mutations that we identified were found in unaffected family members or in more than 100 control chromosomes.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 2. SHOX point mutations identified in this study. Structure of SHOX gene is depicted with coding region shaded. Roman numerals, exons; arabic numerals, amino acid residues. Homeodomain (residues 117–176) shown in black.

 
LWD patient population

Analyses include examination of the effects of age, gender, pubertal status (Tanner 1 vs. Tanner 5), and parent of origin on the LWD phenotype. The clinical features of 43 LWD subjects (32 females and 11 males) are shown in Table 1Go. Phenotypes examined were height, Madelung deformity, and other TS skeletal features: high arched palate, increased carrying angle, and scoliosis. Results are presented as z-scores if age- and gender-specific norms were available. Numbers are specified for each analysis because evaluations have not been completed for all subjects. Ages ranged from 3 to 56 yr. Most were Caucasian, two were African-American, and four were Hispanic. Of 16 adult LWD females, one with a translocation had secondary amenorrhea and premature ovarian failure. The mean age for onset of menarche in the postpubertal females was 12.5 ± 1.5 yr. Ten of the adult women had one or more children.

Analysis of physical features

Height. Age- and gender-specific height z-scores for the LWD subjects ranged from -4.6 to +0.6 SD (mean = -2.2 ± 1.0 SD). Twenty-one subjects (49%) had heights within the normal range (±2 SD). Mean z-score for the ratio of upper segment to lower segment was 2.0 ± 3.3, suggesting short lower limbs. Mean arm span z-score was -2.9 ± 1.0, and the mean height minus arm span was 6.1 ± 4.5 cm, indicating relatively short arms. The mean z-score (age- and gender-adjusted) for right radius length was -2.6 ± 1.0, indicating mesomelia.

The results did not demonstrate any effects of age, gender, pubertal status, or parental origin of SHOX mutations on height z-score. There was no correlation between height z-score and chronologic age (r = 0.08; P = 0.63) (Fig. 3Go). Thus, height deficits were similar in children and adults. The height deficits of affected parents and children within the same family were compared by subtracting the child’s height z-score from the affected parent’s height z-score. Five families with more than one affected child were included in the calculations. There was no significant difference in parents’ and children’s relative heights within families. The mean difference was -0.3 ± 1.5 SD (n = 19 parent-child pairs), demonstrating no apparent age effect within families.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Height deficit of LWD patients vs. chronological age.

 
Height z-scores were similar for female and male LWD subjects: -2.1 ± 1.0 SD vs. -2.3 ± 1.1 SD, respectively (p = 0.59). The effects of gender on height deficits were also examined by subtracting the height z-scores of LWD females from affected LWD males within the same family (n = 12 pairs). The difference (0.0 ± 1.4) was not significant. Height z-score was also similar in prepubertal (Tanner 1, n = 9) vs. postpubertal (Tanner 5, n = 20) females: -2.2 ± 0.9 SD vs. -2.2 ± 1.1 SD, respectively (p = 0.88). Thus, the transition through puberty in females did not affect relative growth.

Height deficits were compared for 25 subjects with SHOX abnormalities of known parental origin. The height z-score of subjects with maternally vs. paternally inherited SHOX abnormalities was -2.2 ± 1.0 (n = 17) vs. -1.8 ± 0.6 SD(n = 8), respectively (P = 0.36). The overrepresentation of maternally inherited SHOX abnormalities may reflect cases due to cytogenetic abnormalities that are only transmitted maternally because they are lethal or cause severe developmental delay in males.

Height deficits of LWD subjects with unbalanced translocations (-2.2 ± 1.1 SD; n = 9) were compared with the other LWD subjects (-2.2 ± 1.0 SD; n = 34), and no differences were found (P = 0.90). Lastly, the height deficit in adult LWD females (-2.2 ± 1.1 SD; n = 18) was less than that of untreated adult TS females (-3.1 ± 1.0 SD; n = 25; P = 0.01).

Madelung wrist deformity. Madelung deformity was diagnosed clinically or radiographically in 32 of 43 (74%) LWD subjects. Results demonstrated effects of gender, age, and pubertal status on the severity but not the initial development of the deformity. Wrist x-rays (Fig. 4Go) were assessed for the presence of radial lucency, subluxation of the ulnar head, z-score for carpal wedging, third metacarpal/radial angle, lunate fossa index, and SD score of the length of the fourth and fifth metacarpals (see Subjects and Methods). Results are shown for the LWD group compared with normal controls, LWD females compared with LWD males, and Tanner 1 LWD females compared with Tanner 5 LWD females (Table 2Go). Multiple measurements differed between LWD patients and controls, including the presence of radial lucency (P < 0.02), subluxation of the ulnar head (P < 0.02), carpal wedging z-score (P < 0.001), third metacarpal/radial angle (P < 0.05), and lunate fossa index (P < 0.008). Radial lucencies were seen in 19 of 39 LWD subjects vs. 0 of 16 control subjects (P = 0.02). The relative length (z-score) of the fourth and fifth metacarpals was similar in LWD and control subjects (Table 2Go).



View larger version (64K):
[in this window]
[in a new window]
 
Figure 4. Radiographic abnormalities of Madelung deformity. Inset shows normal wrist.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Measurements and comparisons from wrist x-rays

 
Correlations of the various measures vs. chronologic age in the LWD population revealed a positive correlation with age for lunate fossa index (r = 0.39; P = 0.02; data not shown); however, this P value is not significant after correction for multiple inferences. Females vs. males were compared (Table 2Go). Radial lucencies were present in 3 of 10 males vs. 16 of 29 females (P = 0.61). Third metacarpal/radial angle differed between females and males, suggesting greater severity of Madelung deformity in females. By contrast, the fourth and fifth metacarpals were shorter in males.

We also examined the relationship of Madelung deformity to pubertal status and, by inference, age because the two are directly related. We compared the measurements in prepubertal Tanner 1 (no breast development) LWD girls vs. mature, Tanner 5 LWD females. The incidence of radial lucencies was similar in children and adults. These results indicate that certain features of Madelung deformity, such as radial lucencies, carpal wedging, and subluxation of the ulnar head, are present in children before puberty, whereas other features, such as lunate fossa index, may progress with pubertal development and increasing age. The number of LWD males was too small to make similar comparisons according to pubertal status of males. Too few x-rays were available for parent of origin analyses for either gender.

The bone ages of LWD patients were assessed. All adults had achieved bone ages of more than 18 yr, indicating epiphyseal fusion. The mean differences in chronologic age minus bone age for girls (n = 13) and boys (n = 6) with bone ages less than 18 yr were 0.3 ± 1.0 and 0.7 ± 0.9 yr, respectively. The numbers were too small to assess developmental changes throughout the childhood years.

Other TS physical features. We also looked at the frequency of other TS-associated features including high arched palate, increased carrying angle, and scoliosis in relation to gender, age, and parent of origin of the SHOX abnormality. The frequency of each respective feature in the LWD population was 59% (24 of 41), 71% (29 of 41), and 22% (9 of 41). High arched palate was present in 55% (17 of 31) of females vs. 70% (7 of 10) of males (P = 0.90). Increased carrying angle was noted in 77% (24 of 31) of females vs. 50% (5 of 10) of males (P = 0.67). Scoliosis was noted in 26% (8 of 31) of females vs. 10% (1 of 10) of males, (P = 0.67). The frequency of these features in LWD females was similar to that of a population of 196 TS (45,X) children and adults (high arched palate, 96%; increased carrying angle, 84%; and scoliosis, 19%; Ross, J. L., unpublished observations). Thus, no significant gender differences were noted for these features. In addition, with the possible exception of high arched palate, the prevalence of these features was similar in LWD and TS.

We compared the occurrence of the above TS-associated features in prepubertal (Tanner 1) LWD children vs. postpubertal (Tanner 2–5) LWD adolescents and adults. Males and females were combined for this analysis because no significant gender differences were seen. High arched palate was present in 12 of 17 prepubertal children vs. 12 of 24 adolescents and adults (P = 0.68). Increased carrying angle was present in 10 of 17 prepubertal children vs. 19 of 24 adolescents and adults (P = 0.73). Scoliosis was present in 0 of 17 prepubertal children vs. 9 of 24 adolescents and adults (P = 0.05). The occurrence of the above features was also compared in parent-prepubertal child pairs. For the three features, six of nine pairs were concordant (both parent and child had or did not have the feature). Three of the adults and none of their prepubertal children had scoliosis. Thus, the developmental trajectory of scoliosis in LWD appears to be similar to that of idiopathic scoliosis.

The occurrence of the above features was also compared in the subjects with a maternally vs. paternally derived SHOX deletion or mutation. High arched palate was noted in 77% (13 of 17) of the maternal group vs. 50% (4 of 8) of the paternal group (P = 0.80). Increased carrying angle was noted in 53% (9 of 17) of the maternal group vs. 50% (4 of 8) of the paternal group (P = 0.77). Scoliosis was noted in 24% (4 of 17) of the maternal group vs. 0% (0 of 8) of the paternal group (P = 0.47). Thus, no significant parent of origin differences were noted for these features, although there was a trend toward more frequent occurrence of high arched palate and scoliosis in subjects with maternal SHOX abnormalities.

Comparison of SHOX point mutations and deletions

Height z-scores of LWD subjects with SHOX point mutations vs. deletions were similar (-2.4 ± 0.8 SD and -2.1 ± 1.1 SD, respectively). Madelung deformity was clinically apparent in 9 of 10 LWD subjects with SHOX mutations vs. 22 of 32 subjects with SHOX deletions. The upper to lower segment ratio z-score was also similar in the two groups (1.1 ± 0.2 SD vs. 1.0 ± 0.2 SD). Height minus arm span was similar (5.3 ± 3.7 vs. 6.1 ± 4.8 cm). The incidence of high arched palate, scoliosis, and increased carrying angle was similar in the two groups.

Discussion

SHOX deletions or mutations were identified in all of our 21 LWD families. We noted mutations in 4 families and deletions in 17 families, similar to the 37.5% mutations and 62.5% deletions recently reported in 16 European LWD families (18). The proportion of families with SHOX abnormalities (100%) was greater than that found by some other studies. This difference may reflect the sensitivity of DHPLC and DNA sequencing to identify point mutations that may have been missed by investigators using other methods such as single-strand conformation polymorphism analysis. One of the mutations (R195X) found in our families was reported by Rao et al. (6) in a subject with idiopathic short stature and also by Clement-Jones et al. (9) and Belin et al. (3) in unrelated LWD patients; thus, it appears to represent a mutational hot spot. SHOX haploinsufficiency alone appears to be responsible for the LWD height deficit as well as the other physical features of LWD because the SHOX point mutations we identified caused similar phenotypes as did complete gene deletions. Conversely, the similarity of the phenotypes suggests that the point mutations are likely loss of function mutations, although a dominant negative effect of R195X cannot be ruled out (19).

We also investigated the potential impact of gender, age, and parent of origin on height of LWD patients and found no significant effects. Interestingly, unlike height, the metacarpals were relatively shorter in LWD men than women, suggesting that gender differences in proportions may be accentuated by SHOX deficiency. The role of imprinting in TS is controversial. Skuse et al. (20) reported differences in the social skills of 45,X TS girls depending upon the parental origin of the single X chromosome. Most researchers have not found imprinting of any TS physical features such as stature. Likewise, we did not detect statistically significant parent of origin effects on the LWD phenotype.

These results are based on a relatively small population subject to ascertainment bias and may not be conclusive. Short stature was found in most subjects, including prepubertal children, but nearly half had heights within the normal range (±2 SD), indicating that severe short stature is not universal. The mean height deficit (-2.2 SD) was less than the height deficit generally observed in TS (-3.2 SD) (11, 21), suggesting that SHOX haploinsufficiency is responsible for approximately two thirds of the height deficit (SD) observed in TS. This would imply that other loci also contribute to the growth impairment in TS. We previously found evidence for a TS height locus in Xp11.2-p22.1, proximal to the pseudoautosomal region (11).

The ratio of females to males in our population was 3:1, demonstrating the female preponderance of LWD. Surprisingly, males and females had similar height deficits, although the Madelung deformity appeared to be more frequent and severe in females. These preliminary results must be interpreted with caution and could be due to under-diagnosis of LWD males or other ascertainment bias. Our results contrast with a previous report that patients with SHOX deficiency and overt dyschondrosteosis show worsening height deficits after puberty (22). Others have suggested that estrogen action is important in the development of dyschondrosteosis (7, 22). Consistent with this hypothesis, there is a reported 4:1 female to male predominance of dyschondrosteosis, and within families, dyschondrosteosis appears to be more common and severe in females (2). Recently, estrogen has been shown to accelerate the programmed senescence of the growth plate, causing earlier fusion (23). Estrogen could have asymmetric effects on the growth plate by interacting with specific SHOX deficient areas.

Madelung deformity was common but not universal in LWD subjects. Curiously, Madelung deformity is relatively uncommon (7%) in TS (24), although virtually all TS females have SHOX haploinsufficiency and short stature. The reasons for the low prevalence of Madelung deformity in TS are not clear. One explanation may be that estrogen exposure influences the development of Madelung deformity. TS girls could be protected from developing Madelung deformity by their sex steroid deficiency, whereas LWD females generally have normal ovarian function. Evidence against this hypothesis is the fact that Madelung deformity was found in some of our prepubertal female and male LWD patients. Radial lucencies, which appear to be an antecedent of the Madelung deformity, were detected in females and males as young as age 3 yr. Furthermore, the deformity does not seem to develop in TS females treated with estrogen before epiphyseal closure (Ross, J. L., unpublished observations). Finally, the SHOX gene is expressed in limbs during early fetal development (9), at which time there is a relatively high circulating estrogen level, but dyschondrosteosis is usually not clinically apparent until adolescence.

An alternative hypothesis to explain the paucity of Madelung deformity in 45,X TS is that modifying effects of loss of nonpseudoautosomal growth genes ameliorate the asymmetric radial growth abnormality that gives rise to Madelung deformity (7). It would be interesting to determine the incidence of radiographic changes such as radial lucency in 45,X TS. Comparisons of the incidence of Madelung deformity and radiographic forme frustes in TS subjects according to karyotype or spontaneous puberty may also help establish the importance of genetic vs. hormonal factors in the etiology of this abnormality.

Our data demonstrated clinical overlap between TS and LWD, consistent with SHOX haploinsufficiency in both disorders. The frequency of skeletal features such as high arched palate, increased carrying angle, and scoliosis was similar in the two groups. Even within these groups, there is considerable phenotypic variability, for unknown reasons. Unfortunately, there is no mouse model for SHOX haploinsufficiency. Thus, humans represent the best system for understanding the role of SHOX in normal and abnormal growth and development.

There are several prevailing notions about LWD phenotypic variability and SHOX deficiency that require further scrutiny. They include: 1) LWD is sex limited, i.e. more common and more severe in females; and 2) puberty or adolescence somehow accentuates LWD features such as Madelung deformity. Our data would confirm that LWD is more common in females, but the males were just as short as the females. This would suggest that males are underdiagnosed and may be part of the idiopathic short stature population in childhood. Careful anthropometric measurements would perhaps permit earlier diagnosis of LWD in affected males. Jackson (25) previously reported that an abnormally low ratio of forearm to upper arm length may be a valuable diagnostic clue. Family history would also provide a clue to the diagnosis because all of the SHOX abnormalities that we observed in males were familial. Second, estrogen may impact on the severity of the Madelung deformity, but its antecedents are present very early in childhood, in both males and females. Most likely, estrogen exposure accentuates the dynamic bony malformation that occurs. Longitudinal studies of a larger population that includes presymptomatic carriers will clarify these issues. In summary, SHOX haploinsufficiency gives rise to LWD and a subset of features of TS. Similarities and contrasts between these two disorders provide insight into the roles of X-linked genes and estrogen on normal bone growth and development.

Acknowledgments

Footnotes

This study was supported in part by NIH Grants NS35554, NS32531, and NS42777.

Abbreviations: DHPLC, Denaturing HPLC; FISH, fluorescence in situ hybridization; LWD, Leri-Weill dyschondrosteosis; SHOX, short stature homeobox-containing gene; TS, Turner syndrome.

Received May 3, 2001.

Accepted July 18, 2001.

References

  1. Leri A, Weill J 1929 Une affection congenitale et symetrique du developpement osseux: la dyschondrosteose. Bull Mem Soc Med Hop (Paris) 53:1491
  2. Langer Jr LO 1965 Dyschondrosteosis, a hereditable bone dysplasia with characteristic roentgenographic features. AJR Amer J Roentgenol 95:178–188
  3. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V 1998 SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genetics 19:67–69[Medline]
  4. Cormier-Daire V, Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A 1999 SHOX gene mutations and deletions in dyschondrosteosis or Leri-Weill syndrome. Acta Paediatr Suppl 88:55–59
  5. Spranger S, Schiller S, Jauch A, Wolff K, Rauterberg-Ruland I, Hager D, Tariverdian G, Troger J, Rappold G 1999 Leri-Weill syndrome as part of a contiguous gene syndrome at Xp22.3. Am J Med Genet 83:367–371[CrossRef][Medline]
  6. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA 1997 Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome [see comments]. Nat Genet 16:54–63[CrossRef][Medline]
  7. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti-Furga A, Scambler PJ, Winter RM 1998 Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 19:70–73[CrossRef][Medline]
  8. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, Drop SL, Troger J, Knoblauch H, Kunze J, Seidel J, Rappold GA 2000 Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur J Hum Genet 8:54–62[CrossRef][Medline]
  9. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA 2000 The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 9:695–702[Abstract/Free Full Text]
  10. Wei F, Cheng S, Badie N, Elder F, Scott Jr C, Nicholson L, Ross JL, Zinn ARA man who inherited his SRY gene and Leri-Weill dyschondrosteosis from his mother and neurofibromatosis type 1 from his father. Am J Med Genet 102:353–358
  11. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA, Guerra R, Kushner H, Schwartz S, Sybert VP, Van Dyke DL, Ross JL 1998 Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 63:1757–1766[CrossRef][Medline]
  12. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM 1979 Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 32:607–629[Abstract/Free Full Text]
  13. Hall JG, Froster-Iskenius UG, Allanson JE 1995 Handbook of normal physical measurements. New York: Oxford University Press
  14. McKusick VA 1972 Heritable disorders of connective tissue. St. Louis, MO: CV Mosby Company
  15. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303
  16. Poznanski AK, Garn SM, Nagy JM, Gall Jr JC 1972 Metacarpophalangeal pattern profiles in the evaluation of skeletal malformations. Radiology 104:1–11[Medline]
  17. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press
  18. Huber C, Cusin V, Le Merrer M, Mathieu M, Sulmont V, Dagoneau N, Munnich A, Cormier-Daire V 2001 SHOX point mutations in dyschondrosteosis. J Med Genet 38:323[Free Full Text]
  19. Zinn AR 1997 Growing interest in Turner syndrome. Nat Genet 16:3–4[CrossRef][Medline]
  20. Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-Leeper G, Bacarese-Hamilton M, Creswell C, McGurk R, Jacobs PA 1997 Evidence from Turner’s syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387:705–708[CrossRef][Medline]
  21. Ogata T, Matsuo N 1995 Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 95:607–629[Medline]
  22. Ogata T, Matsuo N, Nishimura G 2001 SHOX haploinsufficiency and overdosage: impact of gonadal function status [In Process Citation]. J Med Genet 38:1–6[Abstract/Free Full Text]
  23. Weise M, De-Levi, S, Barnes, KM, Gafni RI, Abad V, Baron J 2001 Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 98:6871–6876[Abstract/Free Full Text]
  24. Lippe B 1991 Turner Syndrome. Endocrinol Metab Clin North Am 20:121–152[Medline]
  25. Jackson LG 1985 Dyschondrosteosis: clinical study of a sixth generation family. Proc Greenwood Genet Center 4:147–148



This article has been cited by other articles:


Home page
Eur J OrthodHome page
M. R. Perkiomaki and L. Alvesalo
Palatine ridges and tongue position in Turner syndrome subjects
Eur J Orthod, April 1, 2008; 30(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Marchini, B. Hacker, T. Marttila, V. Hesse, J. Emons, B. Weiss, M. Karperien, and G. Rappold
BNP is a transcriptional target of the short stature homeobox gene SHOX
Hum. Mol. Genet., December 15, 2007; 16(24): 3081 - 3087.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Sabherwal, F. Bangs, R. Roth, B. Weiss, K. Jantz, E. Tiecke, G. K. Hinkel, C. Spaich, B. P. Hauffa, H. van der Kamp, et al.
Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients
Hum. Mol. Genet., January 15, 2007; 16(2): 210 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Bondy and for The Turner Syndrome Consensus Study Group
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
V Cantagrel, A-M Lossi, S Boulanger, D Depetris, M-G Mattei, J Gecz, C E Schwartz, L Van Maldergem, and L Villard
Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males
J. Med. Genet., October 1, 2004; 41(10): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, A. Renz, A. Martinez, A. Keselman, V. Hesse, S. W. Riedl, G. Hausler, S. Fricke-Otto, H. Frisch, J. J. Heinrich, et al.
SHOX Haploinsufficiency and Leri-Weill Dyschondrosteosis: Prevalence and Growth Failure in Relation to Mutation, Sex, and Degree of Wrist Deformity
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4403 - 4408.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
T Tsilchorozidou, F H Menko, F Lalloo, A Kidd, R De Silva, H Thomas, P Smith, A Malcolmson, J Dore, K Madan, et al.
Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2
J. Med. Genet., July 1, 2004; 41(7): 529 - 534.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
N Sabherwal, R J Blaschke, A Marchini, D Heine-Suner, J Rosell, J Ferragut, W F Blum, and G Rappold
A novel point mutation A170P in the SHOX gene defines impaired nuclear translocation as a molecular cause for Leri-Weill dyschondrosteosis and Langer dysplasia
J. Med. Genet., June 1, 2004; 41(6): e83 - e83.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. K. Bakalov, L. Axelrod, J. Baron, L. Hanton, L. M. Nelson, J. C. Reynolds, S. Hill, J. Troendle, and C. A. Bondy
Selective Reduction in Cortical Bone Mineral Density in Turner Syndrome Independent of Ovarian Hormone Deficiency
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5717 - 5722.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, M. B. Ranke, and D. D. Martin
Auxology Is a Valuable Instrument for the Clinical Diagnosis of SHOX Haploinsufficiency in School-Age Children with Unexplained Short Stature
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4891 - 4896.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Roubicek, M. C. Arriazu, and G. Isaac
SHOX Deficiency Phenotypes
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 4004 - 4004.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. G. Rosenfeld
Author's Response: SHOX--A Geneticist's View
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1912 - 1912.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Rappold
SHOX: A Geneticist's View
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1911 - 1912.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. G. Rosenfeld
EDITORIAL: A SHOX to the System
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5672 - 5673.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, J. L.
Right arrow Articles by Zinn, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, J. L.
Right arrow Articles by Zinn, A. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals